Skip to main content
  • FDA Issues Guidance on IDE Trial Live Case Presentations

    FDA Issues Guidance on IDE Trial Live Case Presentations

  • FDA Issues Guidance on IDE Trial Live Case Presentations

    The U.S. Food and Drug Administration (FDA) issued final guidance Wednesday on live case presentations made during investigational device exemption (IDE) clinical trials.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details